Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.750
0.00 (0.00%)
At close: Jul 17, 2026, 4:00 PM EDT
1.770
+0.020 (1.14%)
After-hours: Jul 17, 2026, 6:58 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $74.9 million as of July 17, 2026. Its market cap has increased by 83.76% in one year.
Market Cap
74.90M
Enterprise Value
-20.42M
1-Year Change
83.76%
Ranking
Category
Stock Price
$1.75
ChartMarket Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $74.90M, a decrease of -68.14%. That is a compound annual growth rate of -26.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 74.90M | -1.51% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 95.44M |
| NeOnc Technologies Holdings | 95.43M |
| Biomea Fusion | 93.27M |
| Adicet Bio | 92.72M |
| Cognition Therapeutics | 90.39M |
| Cardiff Oncology | 89.56M |
| LeonaBio | 89.43M |
| NeurAxis | 88.55M |